Transdermal Gel Offers New Option for Gout

Transdermal Gel Offers New Option for Gout

By Alesia Wagner, Chain Drug Review
Gout, an extremely painful form of inflammatory arthritis, affects more than 4% of Americans and about 10% of men over the age of 60. It is more common in women after menopause. The disease occurs due to an excess of the bodily waste uric acid. The acid is deposited as needle-like crystals in the joints or in soft tissue. These crystals cause redness, swelling, stiffness and intense pain in the joints, which in turn can create gout flares.

ColciGel is a new prescription medication for the treatment of acute flares of gout. It is a transdermal gel that contains homeopathic colchicine (colchicinum 4X) that is applied directly to the sites of a flare. ColciGel penetrates the dermal layer, resulting in the reduction of inflammation and pain associated with the flare.

Value Brands for Patients, Physicians, Pharmacies, Payors

Value Brands for Patients, Physicians, Pharmacies, Payors

An interview with Carlos Alfaras, Chief Executive Officer; Gensco Pharma As seen in Chain Drugstore Daily | April 18, 2016 CDD: Tell our readers about Gensco Pharma. CA: Gensco is a specialty pharmaceutical manufacturer focused on developing and...
Got Gout? Announcement

Got Gout? Announcement

Rapid Relief of Pain at the First Sign of Acute Gout Flares Chain Drug Review | May and June 2015                

The Innovator April 2015

Got Pain? … Millions Suffer from Acute or Chronic Pain every year and it is the leading reason for those seeking medical care. Mild to moderate musculoskeletal injuries – Sprains, strains, contusions, repetitive use, and minor trauma – are the most common...
LiDORx® Activation Study

LiDORx® Activation Study

Gensco Pharma Report Demonstrates a Faster Onset of Anesthesia with LiDORx® Gensco sponsored internal testing has demonstrated a greater degree of drug movement across synthetic human skin (in vitro diffusion cell tests), estimated at more than 3 times that of typical...